The somatic symptom burden of patients with medically unexplained oral symptoms across the COVID-19 pandemic: a retrospective cross-sectional study

Background To determine whether COVID-19 pandemic periods were associated with the general somatic symptom burden of patients with medically unexplained oral symptoms (MUOS) and to identify patient-level and diagnostic correlates. Methods This retrospective cross-sectional study included 3,542 adults presenting for initial consultation at a psychosomatic dentistry clinic from April 2017 through September 2025. Somatic burden was assessed using the Somatic Symptom Scale-8 (SSS-8), and depressive symptoms using the Zung Self-Rating Depression Scale (SDS). World Health Organization declarations defined three periods: before the pandemic, during the pandemic, and after the end of the Public Health Emergency of International Concern (PHEIC). Group differences and adjusted associations with SSS-8 scores were examined using analysis of variance, multiplicity-adjusted pairwise tests, and multivariable linear regression with categorical period indicators, without and with SDS adjustment. Results The mean SSS-8 scores were 9.04 (95% CI, 8.73–9.35) in the pre-pandemic period, 9.45 (9.11–9.79) during the pandemic, and 9.63 (9.23–10.04) in the post-PHEIC period. The overall ANOVA was statistically significant ( p = 0.047), but no pairwise comparison remained significant after false-discovery-rate correction. Without SDS adjustment, post-PHEIC scores were higher than pre-pandemic scores (b = 0.66; 95% CI, 0.17–1.15; p = 0.009; joint period p = 0.028). Period estimates were smaller after adding SDS (joint period p = 0.450). In this model, SDS was the strongest correlate (standardized β = 0.542, p < 0.001); psychiatric history, burning mouth syndrome, persistent idiopathic facial pain, and longer illness duration were associated with higher burden, whereas oral cenesthopathy was associated with lower burden. The adjusted R² was 0.329. Conclusions In this sample of patients with MUOS, observed differences in somatic symptom burden across calendar-period samples were small and depended on SDS adjustment. These comparisons cannot establish causal pandemic effects, absence of such effects, or mediation by depressive symptoms. Longitudinal studies incorporating individual pandemic-related exposures are needed.

Authors

Publication Details

Journal
BioPsychoSocial Medicine
Published
2026-11-19
DOI
https://doi.org/10.1186/s13030-026-00378-8
Primary Topic
Psychosomatic Disorders and Their Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The somatic symptom burden of patients with medically unexplained oral symptoms across the COVID-19 pandemic: a retrospective cross-sectional study

Trang Thi Huyen Tu, Akira Toyofuku, Ko Matsudaira, Takayuki Suga et al.
BioPsychoSocial Medicine
Psychosomatic Disorders and Their Treatments
article

The somatic symptom burden of patients with medically unexplained oral symptoms across the COVID-19 pandemic: a retrospective cross-sectional study

Trang Thi Huyen Tu, Akira Toyofuku, Ko Matsudaira, Takayuki Suga, Zhenyan Liu, Motoko Watanabe
article en

Abstract

Background To determine whether COVID-19 pandemic periods were associated with the general somatic symptom burden of patients with medically unexplained oral symptoms (MUOS) and to identify patient-level and diagnostic correlates. Methods This retrospective cross-sectional study included 3,542 adults presenting for initial consultation at a psychosomatic dentistry clinic from April 2017 through September 2025. Somatic burden was assessed using the Somatic Symptom Scale-8 (SSS-8), and depressive symptoms using the Zung Self-Rating Depression Scale (SDS). World Health Organization declarations defined three periods: before the pandemic, during the pandemic, and after the end of the Public Health Emergency of International Concern (PHEIC). Group differences and adjusted associations with SSS-8 scores were examined using analysis of variance, multiplicity-adjusted pairwise tests, and multivariable linear regression with categorical period indicators, without and with SDS adjustment. Results The mean SSS-8 scores were 9.04 (95% CI, 8.73–9.35) in the pre-pandemic period, 9.45 (9.11–9.79) during the pandemic, and 9.63 (9.23–10.04) in the post-PHEIC period. The overall ANOVA was statistically significant ( p = 0.047), but no pairwise comparison remained significant after false-discovery-rate correction. Without SDS adjustment, post-PHEIC scores were higher than pre-pandemic scores (b = 0.66; 95% CI, 0.17–1.15; p = 0.009; joint period p = 0.028). Period estimates were smaller after adding SDS (joint period p = 0.450). In this model, SDS was the strongest correlate (standardized β = 0.542, p < 0.001); psychiatric history, burning mouth syndrome, persistent idiopathic facial pain, and longer illness duration were associated with higher burden, whereas oral cenesthopathy was associated with lower burden. The adjusted R² was 0.329. Conclusions In this sample of patients with MUOS, observed differences in somatic symptom burden across calendar-period samples were small and depended on SDS adjustment. These comparisons cannot establish causal pandemic effects, absence of such effects, or mediation by depressive symptoms. Longitudinal studies incorporating individual pandemic-related exposures are needed.

BioPsychoSocial Medicine
Psychosomatic Disorders and Their Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon